Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.42 USD | -2.43% | +2.30% | +68.33% |
05-09 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+68.33% | 5.97B | |
+3.92% | 111B | |
+11.48% | 105B | |
-13.05% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.29% | 16.96B | |
+2.46% | 13.7B | |
+35.98% | 12.45B |
- Stock Market
- Equities
- IBRX Stock
- News ImmunityBio, Inc.
- ImmunityBio Says Cancer Vaccine Trial Moving to Controlled Phase